Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2024-10-10 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
上海市锦天城律师事务所关于湖北一致魔芋生物科技股份有限公司2024年股权激励计划首次授予相关事项的法律意见书
Regulatory Filings
2024-10-10 Chinese
2024 年股权激励计划权益首次授予公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial grant of equity incentives under the company's 2024 stock incentive plan. It includes information about board and supervisory approvals, the number of shares granted, the grant price, performance targets, and legal opinions. The content focuses on the equity incentive plan implementation and related disclosures rather than financial results or management discussion. It is not an annual or interim report, earnings release, or a regulatory filing about financial performance. It is also not a proxy statement or voting results announcement. The document is a formal announcement of the equity incentive plan's initial grant, which fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure and equity incentives granted to employees and management. The document length and detail confirm it is the announcement itself, not a brief report publication notice or a certification. Therefore, the appropriate classification is CAP with high confidence.
2024-10-10 Chinese
2024年股权激励计划首次授予权益的激励对象名单（首次授予日）
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from 湖北一致魔芋生物科技股份有限公司 regarding the initial grant of equity incentives under the 2024 equity incentive plan. It lists the recipients, their positions, and the number of restricted shares granted. The content focuses on the allocation of stock incentives to directors, senior management, and core employees. There is no financial statement, quarterly or annual report data, or detailed financial analysis. The document is a formal announcement of a share-based compensation plan, which aligns with disclosures about share issues or capital changes. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length is short (1662 characters), and it is not merely an announcement of a report but a substantive disclosure of share allocation details.
2024-10-10 Chinese
湖北陈守邦律师事务所关于湖北一致魔芋生物科技股份有限公司2024年第二次临时股东大会法律意见书
Regulatory Filings
2024-09-29 Chinese
关于认定核心员工的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 湖北一致魔芋生物科技股份有限公司 regarding the recognition of 55 core employees. It details the process of nomination, public notice, supervisory board approval, and final shareholder meeting approval. The content focuses on personnel recognition and internal company decisions rather than financial results, governance rules, or regulatory filings. It is not a financial report, audit, or earnings release. It is also not a board or management change announcement since it concerns core employee recognition, which is a personnel announcement but not senior management changes. The document is a formal announcement of a company decision related to employee recognition, fitting best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2024-09-29 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 second extraordinary shareholders meeting of 湖北一致魔芋生物科技股份有限公司. It includes information about the meeting date, attendance, agenda items, voting results, and legal opinions. The content focuses on shareholder voting outcomes on various proposals related to the 2024 equity incentive plan and related authorizations. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 6,000 characters and contains substantive voting details, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2024-09-29 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.